Notably, this review emphasizes the ability of flavonoids to target critical signaling pathways involved in RCC progression and therapeutic resistance, such as JAK/STAT3, EGFR/PI3K/Akt/mTOR, and CaMKKβ/AMPK/USP51. This evidence concerns the gene EGFR and renal cell carcinoma.